Average Co-Inventor Count = 7.51
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (42 from 1,149 patents)
2. Merck Patent Gmbh (3 from 2,937 patents)
3. Cellarity, Inc. (2 from 3 patents)
44 patents:
1. 12473285 - DCN-1 modulating compounds and methods of use thereof
2. 12435087 - Modulators of DCN-1 and methods of use thereof
3. 12331057 - Modulators of alpha-1 antitrypsin
4. 12251387 - Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
5. 12195453 - Antiproliferation compounds and uses thereof
6. 12005127 - DNA-PK inhibitors
7. 11884672 - Modulators of alpha-1 antitrypsin
8. 11813267 - DNA-PK inhibitors
9. RE49500 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
10. 11623924 - Modulators of alpha-1 antitrypsin
11. 11440907 - Antiproliferation compounds and uses thereof
12. 10973830 - Substituted quinoxaline DNA-PK inhibitors
13. 10815225 - Antiproliferation compounds and uses thereof
14. RE48266 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
15. 10786512 - DNA-PK inhibitors